{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:53:23Z","timestamp":1794243203304,"version":"4.9.0"},"reference-count":39,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"2024 Science and Technology Program for Medicine and Health in Zhejiang Province","award":["2024KY1761"],"award-info":[{"award-number":["2024KY1761"]}]},{"name":"Quzhou Science and Technology Program","award":["2023K112"],"award-info":[{"award-number":["2023K112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Clin Microbiol Antimicrob"],"DOI":"10.1186\/s12941-026-00880-5","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T13:24:58Z","timestamp":1786627498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metagenomic-based quantification of Pseudomonas aeruginosa burden links microbiome collapse to mortality in severe community-acquired pneumonia"],"prefix":"10.1186","volume":"25","author":[{"given":"Junjie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidan","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiancheng","family":"Zhuge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youqin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglong","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaoxiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,13]]},"reference":[{"key":"880_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1136\/thorax-2024-222296","volume":"80","author":"I Martin-Loeches","year":"2025","unstructured":"Martin-Loeches I, Reyes LF, Rodriguez A. Severe community-acquired pneumonia (sCAP): advances in management and future directions. Thorax. 2025;80:565\u201375. https:\/\/doi.org\/10.1136\/thorax-2024-222296.","journal-title":"Thorax"},{"key":"880_CR2","doi-asserted-by":"publisher","first-page":"2371","DOI":"10.1016\/S0140-6736(25)01493-X","volume":"406","author":"LF Reyes","year":"2025","unstructured":"Reyes LF, Conway Morris A, Serrano-Mayorga C, et al. Community-acquired pneumonia. Lancet. 2025;406:2371\u201388. https:\/\/doi.org\/10.1016\/S0140-6736(25)01493-X.","journal-title":"Lancet"},{"key":"880_CR3","doi-asserted-by":"publisher","first-page":"e065871","DOI":"10.1136\/bmj-2021-065871","volume":"375","author":"C Cill\u00f3niz","year":"2021","unstructured":"Cill\u00f3niz C, Torres A, Niederman MS. Management of pneumonia in critically ill patients. BMJ. 2021;375:e065871. https:\/\/doi.org\/10.1136\/bmj-2021-065871.","journal-title":"BMJ"},{"key":"880_CR4","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1001\/jama.2019.21118","volume":"323","author":"G Olson","year":"2020","unstructured":"Olson G, Davis AM. Diagnosis and Treatment of Adults With Community-Acquired Pneumonia. JAMA. 2020;323:885. https:\/\/doi.org\/10.1001\/jama.2019.21118.","journal-title":"JAMA"},{"key":"880_CR5","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1378\/chest.10-0166","volume":"139","author":"S Fujitani","year":"2011","unstructured":"Fujitani S, Sun H-Y, Yu VL, et al. Pneumonia Due to Pseudomonas aeruginosa. Chest. 2011;139:909\u201319. https:\/\/doi.org\/10.1378\/chest.10-0166.","journal-title":"Chest"},{"key":"880_CR6","doi-asserted-by":"publisher","first-page":"e330","DOI":"10.1016\/S2666-5247(23)00031-9","volume":"4","author":"Y-N Liu","year":"2023","unstructured":"Liu Y-N, Zhang Y-F, Xu Q, et al. Infection and co-infection patterns of community-acquired pneumonia in patients of different ages in China from 2009 to 2020: a national surveillance study. Lancet Microbe. 2023;4:e330\u20139. https:\/\/doi.org\/10.1016\/S2666-5247(23)00031-9.","journal-title":"Lancet Microbe"},{"key":"880_CR7","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1093\/evlett\/qrae030","volume":"8","author":"S Lindon","year":"2024","unstructured":"Lindon S, Shah S, Gifford DR, et al. Antibiotic resistance alters the ability of Pseudomonas aeruginosa to invade bacteria from the respiratory microbiome. Evol Lett. 2024;8:735\u201347. https:\/\/doi.org\/10.1093\/evlett\/qrae030.","journal-title":"Evol Lett"},{"key":"880_CR8","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1007\/s00134-013-2828-9","volume":"39","author":"M Tumbarello","year":"2013","unstructured":"Tumbarello M, De Pascale G, Trecarichi EM, et al. Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients. Intensive Care Med. 2013;39:682\u201392. https:\/\/doi.org\/10.1007\/s00134-013-2828-9.","journal-title":"Intensive Care Med"},{"key":"880_CR9","doi-asserted-by":"publisher","first-page":"e150473","DOI":"10.1172\/JCI150473","volume":"131","author":"SA Whiteside","year":"2021","unstructured":"Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest. 2021;131:e150473. https:\/\/doi.org\/10.1172\/JCI150473.","journal-title":"J Clin Invest"},{"key":"880_CR10","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1186\/s40001-026-03892-1","volume":"31","author":"Y Wang","year":"2026","unstructured":"Wang Y, Shen Y, Shen J, et al. Airway microbiome dysbiosis in severe pneumonia: metagenomic evidence of pathogen expansion and commensal depletion. Eur J Med Res. 2026;31:339. https:\/\/doi.org\/10.1186\/s40001-026-03892-1.","journal-title":"Eur J Med Res"},{"key":"880_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13054-022-04068-z","volume":"26","author":"D Fenn","year":"2022","unstructured":"Fenn D, Abdel-Aziz MI, Van Oort PMP, et al. Composition and diversity analysis of the lung microbiome in patients with suspected ventilator-associated pneumonia. Crit Care. 2022;26:203. https:\/\/doi.org\/10.1186\/s13054-022-04068-z.","journal-title":"Crit Care"},{"key":"880_CR12","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1164\/rccm.201907-1487OC","volume":"201","author":"RP Dickson","year":"2020","unstructured":"Dickson RP, Schultz MJ, Van Der Poll T, et al. Lung Microbiota Predict Clinical Outcomes in Critically Ill Patients. Am J Respir Crit Care Med. 2020;201:555\u201363. https:\/\/doi.org\/10.1164\/rccm.201907-1487OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"880_CR13","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/s41576-019-0113-7","volume":"20","author":"CY Chiu","year":"2019","unstructured":"Chiu CY, Miller SA. Clinical metagenomics. Nat Rev Genet. 2019;20:341\u201355. https:\/\/doi.org\/10.1038\/s41576-019-0113-7.","journal-title":"Nat Rev Genet"},{"key":"880_CR14","doi-asserted-by":"publisher","first-page":"e00584","DOI":"10.1128\/spectrum.00584-25","volume":"13","author":"J Zhao","year":"2025","unstructured":"Zhao J, Zhuge R, Guo K, et al. The clinical utility of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised critically ill patients with invasive pulmonary aspergillosis: a multicenter retrospective study. Microbiol Spectr. 2025;13:e00584\u201325. https:\/\/doi.org\/10.1128\/spectrum.00584-25.","journal-title":"Microbiol Spectr"},{"key":"880_CR15","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1186\/s12931-024-02991-z","volume":"25","author":"J Zhao","year":"2024","unstructured":"Zhao J, Sun Y, Tang J, et al. The clinical application of metagenomic next-generation sequencing in immunocompromised patients with severe respiratory infections in the ICU. Respir Res. 2024;25:360. https:\/\/doi.org\/10.1186\/s12931-024-02991-z.","journal-title":"Respir Res"},{"key":"880_CR16","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jare.2021.09.012","volume":"38","author":"Z Diao","year":"2022","unstructured":"Diao Z, Han D, Zhang R, et al. Metagenomics next-generation sequencing tests take the stage in the diagnosis of lower respiratory tract infections. J Adv Res. 2022;38:201\u201312. https:\/\/doi.org\/10.1016\/j.jare.2021.09.012.","journal-title":"J Adv Res"},{"key":"880_CR17","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-025-02520-0","author":"J Zhao","year":"2025","unstructured":"Zhao J, Zhuge R, Hu B, et al. Clinical impact of bronchoalveolar lavage fluid metagenomic next-generation sequencing in immunocompromised patients with severe community-acquired pneumonia in ICU: a multicenter retrospective study. Infection Published Online First. 2025. https:\/\/doi.org\/10.1007\/s15010-025-02520-0.","journal-title":"Infection Published Online First: 23 April"},{"key":"880_CR18","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.chest.2024.07.144","volume":"167","author":"X Wu","year":"2025","unstructured":"Wu X, Sun T, He H, et al. Effect of Metagenomic Next-Generation Sequencing on Clinical Outcomes of Patients With Severe Community-Acquired Pneumonia in the ICU: A Multicenter, Randomized Controlled Trial. Chest. 2025;167:362\u201373. https:\/\/doi.org\/10.1016\/j.chest.2024.07.144.","journal-title":"Chest"},{"key":"880_CR19","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s12866-025-04707-9","volume":"26","author":"J Zhao","year":"2026","unstructured":"Zhao J, Cai W, Zhang X, et al. Exploring lung microbiota and clinical application of BALF-mNGS in patients with pulmonary mycobacterial diseases: a multicenter retrospective study. BMC Microbiol. 2026;26:130. https:\/\/doi.org\/10.1186\/s12866-025-04707-9.","journal-title":"BMC Microbiol"},{"key":"880_CR20","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1086\/511159","volume":"44","author":"LA Mandell","year":"2007","unstructured":"Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America\/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clin Infect Dis. 2007;44:S27\u201372. https:\/\/doi.org\/10.1086\/511159.","journal-title":"Clin Infect Dis"},{"key":"880_CR21","doi-asserted-by":"publisher","first-page":"1439472","DOI":"10.3389\/fcimb.2024.1439472","volume":"14","author":"Y Liu","year":"2024","unstructured":"Liu Y, Wu W, Xiao Y, et al. Application of metagenomic next-generation sequencing and targeted metagenomic next-generation sequencing in diagnosing pulmonary infections in immunocompetent and immunocompromised patients. Front Cell Infect Microbiol. 2024;14:1439472. https:\/\/doi.org\/10.3389\/fcimb.2024.1439472.","journal-title":"Front Cell Infect Microbiol"},{"key":"880_CR22","doi-asserted-by":"publisher","first-page":"ofad565","DOI":"10.1093\/ofid\/ofad565","volume":"10","author":"JA Ramirez","year":"2023","unstructured":"Ramirez JA, Chandler TR, Furmanek SP, et al. Community-Acquired Pneumonia in the Immunocompromised Host: Epidemiology and Outcomes. Open Forum Infect Dis. 2023;10:ofad565. https:\/\/doi.org\/10.1093\/ofid\/ofad565.","journal-title":"Open Forum Infect Dis"},{"key":"880_CR23","doi-asserted-by":"publisher","first-page":"1070581","DOI":"10.3389\/fpubh.2023.1070581","volume":"11","author":"X Wu","year":"2023","unstructured":"Wu X, Sun T, Cai Y, et al. Clinical characteristics and outcomes of immunocompromised patients with severe community-acquired pneumonia: A single-center retrospective cohort study. Front Public Health. 2023;11:1070581. https:\/\/doi.org\/10.3389\/fpubh.2023.1070581.","journal-title":"Front Public Health"},{"key":"880_CR24","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/j.chest.2020.05.598","volume":"158","author":"JA Ramirez","year":"2020","unstructured":"Ramirez JA, Musher DM, Evans SE, et al. Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies. Chest. 2020;158:1896\u2013911. https:\/\/doi.org\/10.1016\/j.chest.2020.05.598.","journal-title":"Chest"},{"key":"880_CR25","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","volume":"30","author":"AM Bolger","year":"2014","unstructured":"Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114\u201320. https:\/\/doi.org\/10.1093\/bioinformatics\/btu170.","journal-title":"Bioinformatics"},{"key":"880_CR26","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357\u20139. https:\/\/doi.org\/10.1038\/nmeth.1923.","journal-title":"Nat Methods"},{"key":"880_CR27","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1186\/s13059-019-1891-0","volume":"20","author":"DE Wood","year":"2019","unstructured":"Wood DE, Lu J, Langmead B. Improved metagenomic analysis with Kraken 2. Genome Biol. 2019;20:257. https:\/\/doi.org\/10.1186\/s13059-019-1891-0.","journal-title":"Genome Biol"},{"key":"880_CR28","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/ije\/dyg054","volume":"32","author":"J Coste","year":"2003","unstructured":"Coste J, Pouchot J. A grey zone for quantitative diagnostic and screening tests. Int J Epidemiol. 2003;32:304\u201313. https:\/\/doi.org\/10.1093\/ije\/dyg054.","journal-title":"Int J Epidemiol"},{"key":"880_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s12931-024-02821-2","volume":"25","author":"J Yang","year":"2024","unstructured":"Yang J, Li J, Zhang L, et al. Highly diverse sputum microbiota correlates with the disease severity in patients with community-acquired pneumonia: a longitudinal cohort study. Respir Res. 2024;25:223. https:\/\/doi.org\/10.1186\/s12931-024-02821-2.","journal-title":"Respir Res"},{"key":"880_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s41479-025-00163-1","volume":"17","author":"L Vidaur","year":"2025","unstructured":"Vidaur L, Guridi A, Leizaola O, et al. Respiratory dysbiosis as prognostic biomarker of disease severity for adults with community-acquired pneumonia requiring mechanical ventilation. Pneumonia. 2025;17:10. https:\/\/doi.org\/10.1186\/s41479-025-00163-1.","journal-title":"Pneumonia"},{"key":"880_CR31","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1080\/22221751.2020.1783188","volume":"9","author":"Y Hu","year":"2020","unstructured":"Hu Y, Cheng M, Liu B, et al. Metagenomic analysis of the lung microbiome in pulmonary tuberculosis - a pilot study. Emerg Microbes Infections. 2020;9:1444\u201352. https:\/\/doi.org\/10.1080\/22221751.2020.1783188.","journal-title":"Emerg Microbes Infections"},{"key":"880_CR32","doi-asserted-by":"publisher","first-page":"e001358","DOI":"10.1136\/bmjresp-2022-001358","volume":"10","author":"Z Ao","year":"2023","unstructured":"Ao Z, Xu H, Li M, et al. Clinical characteristics, diagnosis, outcomes and lung microbiome analysis of invasive pulmonary aspergillosis in the community-acquired pneumonia patients. BMJ Open Resp Res. 2023;10:e001358. https:\/\/doi.org\/10.1136\/bmjresp-2022-001358.","journal-title":"BMJ Open Resp Res"},{"key":"880_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1111\/j.1469-0691.2006.01535.x","volume":"12","author":"M Hoogewerf","year":"2006","unstructured":"Hoogewerf M, Oosterheert JJ, Hak E, et al. Prognostic factors for early clinical failure in patients with severe community-acquired pneumonia. Clin Microbiol Infect. 2006;12:1097\u2013104. https:\/\/doi.org\/10.1111\/j.1469-0691.2006.01535.x.","journal-title":"Clin Microbiol Infect"},{"key":"880_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1465-9921-15-6","volume":"15","author":"F Blasi","year":"2014","unstructured":"Blasi F, Ostermann H, Racketa J, et al. Early versus later response to treatment in patients with community-acquired pneumonia: analysis of the REACH study. Respir Res. 2014;15:6. https:\/\/doi.org\/10.1186\/1465-9921-15-6.","journal-title":"Respir Res"},{"issue":"1","key":"880_CR35","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1164\/rccm.202410-1996OC","volume":"212","author":"N Spottiswoode","year":"2026","unstructured":"Spottiswoode N, Neyton LP, Mick E, et al. Host-Microbe Multiomic Profiling Predicts Mortality in Sepsis. Am J Respir Crit Care Med. 2026;212(1):95\u2013104. https:\/\/doi.org\/10.1164\/rccm.202410-1996OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"880_CR36","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.ijantimicag.2017.09.008","volume":"51","author":"J Liu","year":"2018","unstructured":"Liu J, Yang L, Chen D, et al. Complete sequence of pBM413, a novel multidrug resistance megaplasmid carrying qnrVC6 and bla IMP-45 from pseudomonas aeruginosa. Int J Antimicrob Agents. 2018;51:145\u201350. https:\/\/doi.org\/10.1016\/j.ijantimicag.2017.09.008.","journal-title":"Int J Antimicrob Agents"},{"key":"880_CR37","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1089\/mdr.2020.0420","volume":"27","author":"L-J Wang","year":"2021","unstructured":"Wang L-J, Chen E-Z, Yang L, et al. Emergence of Clinical Pseudomonas aeruginosa Isolate Guangzhou-PaeC79 Carrying crpP, blaGES-5, and blaKPC-2 in Guangzhou of China. Microb Drug Resist. 2021;27:965\u201370. https:\/\/doi.org\/10.1089\/mdr.2020.0420.","journal-title":"Microb Drug Resist"},{"key":"880_CR38","doi-asserted-by":"publisher","first-page":"105124","DOI":"10.1016\/j.micpath.2021.105124","volume":"159","author":"Z Xu","year":"2021","unstructured":"Xu Z, Lin X, Soteyome T, et al. Significant downtrend of antimicrobial resistance rate and rare \u03b2-lactamase genes and plasmid replicons carriage in clinical Pseudomonas aeruginosa in Southern China. Microb Pathog. 2021;159:105124. https:\/\/doi.org\/10.1016\/j.micpath.2021.105124.","journal-title":"Microb Pathog"},{"key":"880_CR39","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.micpath.2017.06.018","volume":"110","author":"J Xie","year":"2017","unstructured":"Xie J, Yang L, Peters BM, et al. A 16-year retrospective surveillance report on the pathogenic features and antimicrobial susceptibility of Pseudomonas aeruginosa isolates from FAHJU in Guangzhou representative of Southern China. Microb Pathog. 2017;110:37\u201341. https:\/\/doi.org\/10.1016\/j.micpath.2017.06.018.","journal-title":"Microb Pathog"}],"container-title":["Annals of Clinical Microbiology and Antimicrobials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12941-026-00880-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12941-026-00880-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T05:19:37Z","timestamp":1789017577000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12941-026-00880-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,13]]},"references-count":39,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["880"],"URL":"https:\/\/doi.org\/10.1186\/s12941-026-00880-5","relation":{},"ISSN":["1476-0711"],"issn-type":[{"value":"1476-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,13]]},"assertion":[{"value":"8 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Quzhou People\u2019s Hospital (2025\u2009\u2212\u2009162). Due to the retrospective design and use of anonymized data, the requirement for written informed consent was waived.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33"}}